Open report — full analysis, no account required.

Sign up to generate reports and read filings that aren't on the open list.

Sign up free

Get notified when ASPI files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts
NASDAQ: ASPI ASP Isotopes Inc. 8-K

ASP Isotopes subsidiary signs Texas A&M research pact to advance uranium conversion tech

Filed July 21, 2026 · Period ending July 21, 2026 · ~1 min read

3 key changes 2 high relevance 1 section

Key Changes

  • high

    Quantum Leap Energy (wholly-owned subsidiary) entered research agreement with Texas A&M Engineering Experiment Station to develop uranium conversion technology producing high-purity uranium hexafluoride from yellowcake uranium.

    Item 7.01 — Regulation FD Disclosure verify on EDGAR →
  • high

    Research targets fundamental data on conversion reactions to improve efficiency, reduce costs, and support scale-up of domestic uranium conversion capabilities—critical given U.S. has only one operating commercial conversion facility.

    Exhibit 99.1 view on EDGAR →
  • medium

    Study aims to strengthen engineering basis for QLE's conversion technology commercialization and contribute to more resilient U.S. nuclear fuel supply chain by reducing foreign dependence.

    Exhibit 99.1 view on EDGAR →

Summary

ASP Isotopes disclosed that its wholly-owned subsidiary Quantum Leap Energy signed a research agreement with Texas A&M Engineering Experiment Station to advance uranium conversion technology. The partnership focuses on collecting fundamental physicochemical data on reactions that convert yellowcake uranium into uranium hexafluoride, a critical feedstock for nuclear fuel enrichment.

The research is designed to improve production efficiency, reduce costs, and support scale-up of domestic conversion capabilities. The strategic context matters for investors: the United States currently has only one operating commercial uranium conversion facility, creating a supply chain vulnerability. Expanding domestic conversion capacity addresses energy security concerns and reduces reliance on foreign sources.

The agreement positions QLE to develop technology that could fill this infrastructure gap, though the research is at an early stage focused on data collection and process optimization rather than immediate commercial deployment. Success would strengthen the engineering foundation for QLE's eventual commercialization efforts in the nuclear fuel cycle.

Section-by-Section Diff

Event · Exhibit 99.1

ASP Isotopes' subsidiary QLE signed a research agreement with Texas A&M to advance uranium conversion technology for domestic nuclear fuel supply.

3 Added
Added QLE-TEES research agreement high

Added in current filing · view on EDGAR →

Quantum Leap Energy LLC (“we,” "QLE" or the "Company"), a wholly-owned subsidiary of ASPI dedicated to advancing innovative technologies and processes across critical segments of the fission and fusion nuclear fuel cycle, has signed a research agreement with the Texas A&M Engineering Experiment Station (TEES) to advance and de-risk the commercial production of high-purity uranium hexafluoride (UF6), a critical feedstock in the existing nuclear fuel enrichment supply chain.

ASP Isotopes' wholly-owned subsidiary Quantum Leap Energy entered into a research agreement with Texas A&M Engineering Experiment Station to develop uranium conversion technology. The agreement focuses on collecting fundamental physicochemical data on reactions involved in producing uranium hexafluoride from yellowcake uranium, a process critical to the nuclear fuel supply chain. The research aims to improve production efficiency, reduce costs, and enhance scalability of domestic uranium conversion capabilities.

Added Research scope and objectives medium

Added in current filing · view on EDGAR →

Bringing together QLE's fuel cycle knowledge and TEES' research capabilities, the agreement focuses on collecting fundamental physicochemical data on the reactions involved in producing UF6 from yellowcake uranium (U3O8), a process known as uranium conversion. The work is intended to support efforts to improve production technology, reduce costs, and enhance scalability. The study is expected to generate data to help identify opportunities to improve conversion efficiency of U3O8 into UF6, an essential intermediate feedstock used in the production of enriched uranium for advanced nuclear energy applications, while supporting process design, modeling, scale-up activities, and the optimization of production pathways.

The research agreement targets fundamental data collection on uranium conversion reactions to transform yellowcake uranium into uranium hexafluoride. The study aims to identify opportunities to improve conversion efficiency and support process design, modeling, and scale-up activities. The resulting insights are expected to strengthen the engineering basis for QLE's conversion technology commercialization efforts and contribute to a more resilient U.S. nuclear fuel supply chain.

Added Strategic rationale high

Added in current filing · view on EDGAR →

Today, the United States has only one operating commercial conversion facility, making the expansion of domestic conversion capabilities essential to strengthening our nation’s energy security and reducing reliance on foreign sources.

The agreement addresses a critical gap in U.S. nuclear fuel infrastructure. With only one operating commercial uranium conversion facility in the United States, expanding domestic conversion capabilities is essential for energy security and reducing foreign dependence. Uranium conversion transforms yellowcake into uranium hexafluoride, the feedstock required for uranium enrichment used throughout most of the world.

Was this report useful?

Figures/quotes linked to EDGAR · Narrative written by AI · Jul 22, 2026 · How we verify